Our findings suggest that CB13 exhibits powerful anti-cancer effects through PPARɣ expression in NSCLC cells, (similar to Cig), and knocking down PPARɣ inhibits CB13-induced PPARɣ expression and cell death. The gene discussed is PPARA; the disease is non-small cell lung carcinoma.